| Literature DB >> 35815206 |
Paige A Shaw1, Ewan Forsyth1, Fizza Haseeb1, Shufan Yang1, Mark Bradley1, Maxime Klausen1.
Abstract
The way in which photons travel through biological tissues and subsequently become scattered or absorbed is a key limitation for traditional optical medical imaging techniques using visible light. In contrast, near-infrared wavelengths, in particular those above 1000 nm, penetrate deeper in tissues and undergo less scattering and cause less photo-damage, which describes the so-called "second biological transparency window". Unfortunately, current dyes and imaging probes have severely limited absorption profiles at such long wavelengths, and molecular engineering of novel NIR-II dyes can be a tedious and unpredictable process, which limits access to this optical window and impedes further developments. Two-photon (2P) absorption not only provides convenient access to this window by doubling the absorption wavelength of dyes, but also increases the possible resolution. This review aims to provide an update on the available 2P instrumentation and 2P luminescent materials available for optical imaging in the NIR-II window.Entities:
Keywords: fluorescent imaging; infrared dyes; near-infrared II; pulsed lasers; tissue penetration; two-photon absorption; two-photon microscopy
Year: 2022 PMID: 35815206 PMCID: PMC9263132 DOI: 10.3389/fchem.2022.921354
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Absorption and scattering coefficients of endogenous chromophores, tissues, and water over the visible and SWIR wavelengths (200–2000 nm). The downwards arrows represent the tissue penetration of light at these wavelengths, according to the values reported for human skin in ref. (Bashkatov et al., 2005). Dashed, dotted and solid outlines on penetration arrows represent the increase in imaging resolution with increased wavelengths. Adapted from values reported in ref (Jacques, 2015). and references therein.
FIGURE 2(Left) Simplified Jablonski diagram illustrating the double-photon absorption and single-photon emission involved in 1PA vs. 2PA excitation (Middle) Demonstrates the quadratic excitation that arises in 2PA vs. 1PA, due to the requirement of two photons having to arrive simultaneously at a sample to result in excitation (Right) The resulting tissue is capable of producing fluorescence emission due to the location of the excitation photons in 2PA vs. 1PA, resulting in more focused, high-resolution images in 2PA fluorescence imaging.
FIGURE 3Overview of fluorophore categories and potential biomedical applications with 2PA NIR-II imaging.
1PA, 2PA and emission properties of NIR-II chromophores reported in literature. Solvent and method of 2P properties are also noted for comparison.
| Probe | Chemical structure | Solvent | λ1PA max | λem max | Φf | 2λ1PA max | λ2PA | σ2 (λ) | σ2 (λ)Φf | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|
| (nm) | (nm) | (nm) | (nm) | (GM) | (GM) | |||||
|
| ||||||||||
| Disodium fluorescein |
| pH11 | 497 | 518 | 0.90 | 994 | 1000 | 2.7 | 2.4 | ( |
| PhenGreen FL (diacetate, uncomplexed) |
| PBS | 492 | 517 | 0.80 | 984 | 1074 | n.d. | n.d. | ( |
| Rhodamine 6G |
| MeOH | 519 | 546 | 0.95 | 1038 | 1060 | 10 | 9.5 | ( |
| Rhodamine B |
| MeOH | 553 | 627 | 0.70 | 1106 | 1040 | 39 | 27 |
|
| Rhodamine 101 |
| EtOH | 570 | 591 | 1.0 | 1140 | 1060 | 20 | 20 | ( |
| Rhodamine 123 |
| PBS | 507 | 529 | 0.90 | 1014 | 1090 | n.d. | n.d. | ( |
| Alexa Fluor 488 |
| NaPhos | 491 | 519 | 0.92 | 980 | 1000 | 21 | 19 | ( |
| Alexa Fluor 546 |
| PBS | 553 | 573 | 0.79 | 1112 | 1028 | n.d. | n.d. | ( |
| Alexa Fluor 568 |
| PBS | 578 | 603 | 0.69 | 1156 | 1060 | n.d. | n.d. | ( |
| Alexa Fluor 594 |
| PBS | 594 | 617 | 0.66 | 1180 | 1074 | n.d. | n.d. | ( |
| Alexa Fluor 610 |
| PBS | 612 | 628 | – | 1224 | 1010 | n.d. | n.d. | ( |
| Alexa Fluor 633 |
| H2O | 632 | 647 | – | 1264 | 1260 | n.d. | <5 | ( |
| MitoTracker Red |
| PBS | 579 | 599 | 0.15 [187] | 1158 | 1133 | n.d. | n.d. | ( |
| CellTracker Red |
|
| 585 | 602 | n.d. | 1170 | 1080 | n.d. | n.d. | ( |
| Lissamine Rhodamine-IgG |
| PBS | 570 | 590 | 0.33 [188] | 1140 | 1116 | n.d. | n.d. | ( |
| Texas Red-IgG |
| PBS | 596 | 615 | 0.90 | 1192 | 1150 | n.d. | n.d. | ( |
| ATTO 680 |
|
| 681 | 698 | 0.30 | 1362 | 1260 | n.d. | n.d. | ( |
| Nile Red |
| MeOH | 550 | 636 | 0.40 | 1100 | 1057 | 104 | 42 | ( |
| |
| MeOH | 554 | 631 | 0.43 | 1108 | 1055 | 183 | 79 | ( |
| |
| MeOH | 569 | 632 | 0.45 | 1065 | 1050 | 123 | 55 | ( |
| |
| MeOH | 565 | 638 | 0.35 | 1130 | 1057 | 232 | 81 | ( |
|
| ||||||||||
| Cy3-IgG ( |
| PBS | 548 | 563 | 0.1 | 1096 | 1032 | n.d. | n.d. | ( |
| Cy5 ( |
| H2O | 646 | 662 | 0.28 | 1292 | 1220 | 143 | ≈40 | ( |
| Cy5.5 ( |
| H2O | 673 | 691 | 0.21 | 1346 | 1280 | 286 | ≈60 | ( |
| Cy7 ( |
| H2O | 750 | 773 | 0.30 | 1500 | 1320 | 200 | ≈60 | ( |
| |
| DMSO | 753 | 780 | 0.17 | 1506 | 1552 | 240 | 41 | ( |
| ICG ( |
| DMSO | 794 | 817 | 0.12 | 1588 | 1552 | 590 | 71 | ( |
| Cypate ( |
| DMSO | 796 | 817 | 0.13 | 1592 | 1552 | 520 | 68 | ( |
| |
| DMSO | 809 | 829 | 0.07 | 1618 | 1552 | 900 | 63 | ( |
| DTTC ( |
| DMSO | 771 | 800 | 0.80 | 1542 | 1552 | 160 | 128 | ( |
| DODCI ( |
| EtOH | 582 | 610 | 0.87 | 1164 | 1060 | 38 | n.d. | ( |
| IR-140 ( |
| DMSO | 825 | ≈840 | 0.06 | 1640 | 1552 | 950 | 57 | ( |
| |
| CH2Cl2 | 1064 | ≈1080 | 0.05 | 2128 | 1800 | 2250 | 113 | ( |
| CH3CN | 1043 | ≈1065 | 0.05 | 2086 | 1800 | 1050 | 53 | |||
| |
| EtOH | 650 | 665 | n.d. | 1300 | 1180 | 140 | n.d. | ( |
| |
| EtOH | 690 | 704 | n.d. | 1380 | 1260 | 150 | n.d. | ( |
| |
| EtOH | 770 | n.d. | n.d. | 1540 | 1340 | 60 | n.d. | ( |
| |
| EtOH | 824 | n.d. | n.d. | 1648 | 1480 | 600 | n.d. | ( |
| Alexa Fluor 647 ( |
| H2O | 650 | 665 | 0.33 | 1300 | 1240 | 133 | ≈44 | ( |
| Alexa Fluor 680 ( |
| H2O | 679 | 702 | 0.36 | 1358 | 1280 | 203 | ≈73 | ( |
| Alexa Fluor 700 ( | – | H2O | 702 | 723 | 0.25 | 1404 | 1320 | 208 | ≈52 | ( |
| Alexa Fluor 750 ( | – | H2O | 753 | 778 | 0.12 | 1506 | 1320 | 292 | ≈35 | ( |
| |
| MeOH | 532 | 636 | 0.44 | 1064 | 1064 (900) | 23 (570) | 10 | ( |
| |
| MeOH | 573 | 708 | 0.33 | 1146 | 1146 | 225 | 74 | ( |
| |
| MeOH | 549 | 673 | 0.54 | 1098 | 1098 | 137 | 74 | ( |
| |
| Toluene | 643 | 654 | 0.62 | 1286 | 1198 | 133 | 82 | ( |
| |
| Toluene | 700 | 714 | 0.75 | 1400 | 1274 | 100 | 75 | ( |
| Styryl 9M ( |
| CHCl3 | ≈625 | ≈790 | 0.10 [189] | ≈1250 | 1240 | 780 | 78 | ( |
| FM4-64 ( |
| PBS | 471 | 691 | n.d. | 942 | 1047 | n.d. | n.d. | ( |
| TO-PRO-3 ( |
| H2O | 641 | 657 | n.d. | 1284 | 1110 | n.d. | n.d. | ( |
| |
| THF | 562 | 598 | 0.07 | 1124 | 1070 | 167 | 12 | ( |
| |
| THF | 615 | 655 | 0.02 | 1230 | 1150 | 214 | 4 | ( |
|
| ||||||||||
| |
| CCl4 | ≈770 | ≈780 | n.d. | ≈1540 | 1020 | 470 | n.d. | ( |
| |
| CCl4 | ≈685 | ≈700 | n.d. | ≈1370 | 1270 | 13 | n.d. | ( |
| |
| CHCl3 | ≈525 | 710 | n.d. | ≈1050 | ≈1040 | ≈2000 | n.d. | ( |
|
| ||||||||||
| LysoTracker Red ( |
| PBS | 577 | 590 | 0.07 | 1154 | 1100 | n.d. | n.d. | ( |
| BODIPY-TR ( |
| MOPS | 589 | 616 | 0.90 | 1178 | 1060 | 269 | 242 | ( |
| IR-07 ( |
| CH2Cl2 | ∼700 | 750 | 0.30 | ∼1400 | 1310 | 101 | 30 | ( |
| |
| THF | 755 | 830 | 0.09 | 1560 | 1064 | n.d | n.d | ( |
|
| ||||||||||
| |
| NPs (Aq.) | 480 | 678 | 0.17 | 960 | 1040 | 5.6 × 105 | 9520 | ( |
| |
| H2O (0.1% DMSO) | 530 | 740 | n.d. | 1060 | 1100 | n.d. | n.d. | ( |
| |
| H2O | 510 | 676 | 0.22 | 1020 | 1040 | 440 | 97 | ( |
| |
| CH2Cl2 | 660 | 785 | 0.005 | 1320 | 1300 | 500 | 2.5 | ( |
| |
| CH2Cl2 | 678 | 782 | 0.0005 | 1356 | 1300 | 1400 | 0.7 | ( |
| |
| H2O | ≈600 | ≈725 | 0.21 | ≈1200 | 1200 | 1.21 × 103 | 242 | ( |
| |
| CHCl3 | 634 | 704 | 0.16 | 1268 | 1250 | 920 | 147 | ( |
| |
| CHCl3 | 668 | 807 | 0.02 | 1336 | 1250 | 1200 | 24 | ( |
| |
| CHCl3 | 1088 | 1120 | 0.002 | 2176 | 2200 | 1300 | 2.6 | ( |
| |
| CHCl3 | 1136 | 1193 | 0.0002 | 2272 | 2300 | 1500 | 0.3 | ( |
| Propidium iodide ( |
| PBS | 536 | 617 | 0.20 | 1072 | 1015 | n.d. | n.d. | ( |
|
| ||||||||||
| |
| NP (aq.) | 613 | 790-810 | 0.14 | 1226 | 1040 | 16100 | 2240 | ( |
| |
| NP (aq.) | 454 | ≈700 | 0.19 n.d. | 908 | 1200 n.d. | 76300 n.d. | 14500 | ( |
| |
| NP (aq.) | ≈479 | ≈627 | 0.06 n.d. | ≈960 | 1040 n.d. | 3200 n.d. | 192 | ( |
| |
| NP (aq.) | 510 | 709 | 0.14 (solid state) | 1020 | 1000 n.d. | ≈520 n.d. | 73 | ( |
| |
| NP (aq.) | 538 | 755 | 0.02 (solid state) | 1076 | 1020 n.d. | 887 n.d. | 18 | ( |
| |
| NP (aq.) | 522 | 620 | 0.05n.d. | 1044 | 1040 n.d. | 2.9 ×106n.d. | 1.5 × 105n.d. | ( |
|
| ||||||||||
| | SWCNT-based dopamine sensor | H2O | 600–1000 | 1000–1265 | 0.0023 | – | 1560 | 216000 | 497 | ( |
| | Aptamer-modified graphene oxide | H2O | 440–720 | 500–650 | 0.34 | – | 1120 | 36000 | 12240 | ( |
| | CDs prepared from urea and citric acid | H2O | 540 | 624 | 0.06 | 1080 | 1200 | n.d. | n.d. | ( |
| | Carbon quantum dots prepared from tris(4-aminophenyl)amine | H2O | 592 | 615 | 0.84 | 1184 | 1100 | n.d. | n.d. | ( |
| | AuNP with SWCNT | H2O | 500–1100 | 775 | n.d. | – | 1100 | n.d. | n.d. | ( |
| | Au25 cluster | H2O | 675 | 830 | <0.001 | 1350 | 1290 | 2700 | n.d. | ( |
| | PEG-dithiolane AuNC | H2O | 355, 670 | 820 | 0.08 | 1370 | 1100 | 300 | 24 | ( |
| | Mn2+-ZnS QD | H2O | 318 | 586 | 0.65 | 636 | 1180 | 265 | 172 | ( |
| | PbS/CdS QD | H2O | 665 | 1270 | 0.18 | 1330 | 1550 | 530 | 95 | ( |
| QD605 ( | polymer-encapsulated CdSe-ZnS QD | H2O | 350–475 | 605 | 0.71 | – | 1000 | 66200 | 47000 | ( |
|
| ||||||||||
| tdTomato ( | – | H2O | 554 | 581 | 0.72 | 1108 | 1050 | 278 | 200 | ( |
| tdKatushka2 ( | – | H2O | 588 | 633 | 0.44 | 1176 | 1100 | 143 | 63 | ( |
| dsRed2 ( | – | H2O | 561 | 587 | 0.71 | 1126 | 1050 | 103 | 73 | ( |
| HcRFP ( | – | PBS | 592 | 645 | 0.05 | 1184 | 1160 | 720 | 36 | ( |
| mCherry ( | – | H2O | 587 | 610 | 0.24 | 1174 | 1080 | 27 | 6.4 | ( |
| mBanana ( | – | H2O | 540 | 553 | 0.69 | 1080 | 1070 | 64 | 44 | ( |
| mStrawberry ( | – | H2O | 574 | 596 | 0.34 | 1148 | 1070 | 20 | 6.8 | ( |
| mRFP ( | – | H2O | 584 | 611 | 0.30 | 1168 | 1080 | 44 | 13 | ( |
| TagRFP ( | – | H2O | 555 | 584 | 0.44 | 1110 | 1050 | 95 | 42 | ( |
| mOrange ( | – | H2O | 548 | 565 | 0.70 | 1096 | 1080 | 67 | 47 | ( |
| eqFP650 ( | – | H2O | 592 | 646 | 0.19 | 1184 | 1112 | 45 | 8.5 | ( |
| Katushka ( | – | H2O | 588 | 635 | 0.35 | 1176 | 1080 | 66 | 23 | ( |
| Katushka2( | – | H2O | 588 | 633 | 0.44 | 1176 | 1140 | 62 | 27 | ( |
| mKate ( | – | pH8 | 588 | 635 | 0.27 | 1176 | 1118 | 52 | 14 | ( |
| mKate2 ( | – | H2O | 588 | 633 | 0.42 | 1176 | 1140 | 72 | 30 | ( |
| mNeptune ( | – | H2O | 600 | 651 | 0.17 | 1200 | 1104 | 70 | 12 | ( |
| mRaspberry ( | – | H2O | 598 | 625 | 0.19 | 1196 | 1118 | 31 | 5.8 | ( |
| Neptune ( | – | H2O | 600 | 647 | 0.22 | 1200 | 1104 | 72 | 16 | ( |
| tdRFP ( | – | Aq. buffer | 584 ( | 579 | 0.68 | 1168 | 1110 | 20 | 13.7 | ( |
Two-photon absorption cross-section value taken at the excitation wavelength λ2PA reported by the authors in the NIR-II window; note that this may differ from the maximum of the 2PA band. Value extrapolated from the data available and from the formula of the 2P brightness (= σ2 (λ) × ΦF).
1P properties as reported by commercial suppliers, reported in water unless indicated otherwise.
Chemical structures are propriety and undisclosed.
Chirality-dependant.
Excitation-dependant.
Properties extracted from the fluorescent protein database (Available at https://www.fpbase.org/, Accessed on 11/04/2022).
Benefits associated with Fibre lasers over traditional solid-state and OPO lasers (adapted from ref (RPMC, 2020))
| Solid-State/OPO-Based Lasers | Femtosecond Fibre Lasers |
|---|---|
| Large cumbersome design | Lightweight, up to 10x smaller |
| Expensive | Affordable |
| Less consistent pulse duration | Pulse duration always maintained |
| Lower power at long wavelengths (crystal-based amplifiers) | Maintains high power at long wavelengths (up to 4W at 920 nm) |
| Water-cooled | Air-cooled |
| High cost of ownership | Low maintenance and engineer fees (fast return on investment potential) |
Current examples of 2PA in vivo experiments performed using NIR-II absorbing fluorophores.
| λ2PA (nm) | Imaging System | Laser used | λem (nm) | Contrast media | Depth (µm) | Animal model | Biological media imaged | Administration Method | Toxic. Test | Year | Ref |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1550 | Home-built system | PolarOnyx Mercury | 800 | DTTC dye ( | 180 | Mouse | Resected kidney vasculature | Intravenous injection | N | 2011 |
|
| 1200 | Commercial Leica TCS SP8 MP | Laser with | 630 | Squaraine | 40 | Mouse | Ear vasculature | Ear blood vessel injection | N | 2019 |
|
| 1057 | Home-built with BioRad MRC 600 confocal microscope | Nd:YLF | ∼590 | FM4-64 dye ( | 45 | Zebrafish embryo | Body | Pre-stained | N | 1996 |
|
| 1040 | Home built with Olympus, BX61 FV1200 microscope | Yb-doped photonic crystal | ∼700 | Triphenylamine dipole | 1200 | Mouse | Ear vasculature Brain vasculature Resected tumour vasculature | Tail vein injection | Y | 2017 |
|
| 1100 | Commercial Olympus FVMPE-RS | InSight® DS with | 740 | PDT-imaging agent 60 | 210 | Mouse | Resected tumour vasculature | Intravenous injection | Y | 2021 |
|
| 1200 | Commercial Olympus FVMPE-RS | InSight® DS with | ∼700 | BTZ SNPs ( | 1010 | Mouse | Brain vasculature | Rectoorbital injection | N | 2019 |
|
| 1300 | 1. Home built with Olympus, BX61W1- FV1200 microscope 2. Home-Built system | 1. PHAROS-10W with | 810 | AIEDots of BTZ dye | 1065 | Mouse | Ear vasculature Brain vasculature | Tail vein injection | Y | 2018 |
|
| 1040 | Home built with Olympus, BX61 FV1200 microscope | Mira HP and Mira | 790 | AIEDots of BTZ dye | 750 | Mouse | Brain vasculature | Tail vein injection | N | 2021 |
|
| 1200 | Commercial Olympus FVMPE-RS | InSight® DS with | ∼700 | AIEDots of BTZ dye | 800 | Mouse | Brain/Ear tumour vasculature | Rectoorbital injection | Y | 2019 |
|
| 1040 | Nikon A1 Confocal Microscope | Laser with | ∼650 | AIEDots of triphenylamine dye | 800 | Mouse | Brain vasculature | Retro orbital injection | Y | 2021 |
|
| 1040 | Home built with Olympus, BX61W1-FV1000 | Yb-doped photonic crystal | ∼620 | AIEDots of BODIPY dye | 700 | Mouse | Brain vasculature | Intravenous injection | Y | 2015 |
|
| 1100 | Commercial Leica SP8 DIVE | Laser with | 615 | Carbon quantum dots | 500 | 1. Zebrafish larvae | 1. Zebrafish Body (2PA) | 1. Dots added to media | 1. N 2. Y | 2020 |
|
| 1550 | Home built with Olympus, BX61 FV1200 microscope | FLCPA-01C Calmar | 1270 | PbS/CdS quantum dots | 220 | Brain vasculature | Intravenous injection | N | 2022 |
| |
| 1070 | Home built system | Ti:Sapphire laser with | ∼580 | Red Fluorescent Protein (tdTomato | 300–500 | Mouse | Brain neurons | Gene Expression (Six3 gene) | N | 2013 |
|
FIGURE 4(Left) Illustration of AIEgen molecules in solution and aggregated state, and their corresponding simplified Jablonski diagrams showing the effect of motion restriction on the radiative (kr) and non-radiative (knr) relaxation pathways after 1PE or 2PE. (Right) Example of in vivo application of 2P microscopy with NIR-II-responsive AIEDots used to reconstruct images of a mouse brain. The 3D reconstruction of mouse brain vasculature is reprinted with permission from ref. (Qi et al., 2018). Copyright 2018 American Chemical Society.
FIGURE 5(A) 2PA spectrum of Mn2+-doped ZnS QDs in the range from 1050 to 1300 nm reported by Subha et al. (B) Comparison of σ2 values in Mn2+-doped ZnS QDs (curve g) with other standard chromophores (curves a–f) and fluorescent proteins (curves h–m): (a) Rhodamine B, (b) Fluorescein, (c) Coumarin 307, (d) Cascade blue, (e) Dansyl and (f) Lucifer Yellow), and (h) tdTomato, (i) mBanana (j) mRFP (k) mCherry (l) mStrawberry (m) mTangerine). Reprinted with permission from ref. (Subha et al., 2013). Copyright 2013 American Chemical Society.
FIGURE 61PA and 2PA spectra of fluorescent proteins of the “fruit series”. Left axis shows the 2PA cross-section σ2 (λ) per mature chromophore, right axis shows corresponding σ2 (λ)Φf values. Adapted with permission from ref. (Drobizhev et al., 2009). Copyright 2009 American Chemical Society.
FIGURE 7The approximate 5-years costs of traditional tunable 2PA lasers (green) and alternative fixed wavelengths lasers (yellow), demonstrating the economical benefits of fixed wavelength fibre lasers. Reproduced from the supplementary material of ref (Mohr et al., 2020) with permission from the authors.
FIGURE 82PA images of brain blood vessels in a mouse injected with CP dots. (a,b) 3D reconstructed second-harmonic generation images of mouse skull. (c–h) 2PA images at various vertical depths (0–400 μm) at 1200 nm excitation, 660–750 nm emission. (i–l) 3D reconstructed 2PA images of brain blood vessels. (m) comparison of 2PA images at excitation wavelengths of 800, 1040, and 1200 nm, of brain vasculature in a mouse injected with polymer dots. 2PA line intensity profiles with the different wavelengths across the blood vessels on the right were also acquired for the corresponding depths. Emission at 660–750 nm. Reprinted from ref (Wang et al., 2019b). with permission from John Wiley and Sons.
FIGURE 9Plot of the 2P brightness and corresponding NIR-II wavelengths of the contrast agents presented in this review (σ2Φf > 24 GM). The 2P contrast agents used in vivo are represented with a framed number. For clarity, a linear scale for brightnesses between 0 and 100 GM, and a logarithmic scale above 100 GM. The typical range of wavelengths covered by common SWIR lasers is shown for reference (power attenuation is represented by the fading colour; note that OPOs and OPAs can extend past 2000 nm).